Friday, July 12, 2019 2:40:07 PM
Compiled:GENETIC ISSUES - SEX and more 07/12/19
Genomic and epigenomic biomarkers are the key to precision medicine.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149763601
____________________________________________________________________________________________
GENETICS INFORMING TRIALS AND PRACTICE:
PHARMACOLOGY + GENOMIC = PHARMACOGENOMICS
The ideal pharmacogenomics test will be able to determine:
• Potential for a medication to be effective – for this person
• The best dose of a medication – for this person
• Avoid risk of serious side effects - for this person
https://www.anavex.com/wp-content/uploads/2019/04/Anavex-Presentation-April-2019.pdf
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149157245
- above is cut and pasted from a georgejjl post
Evolution of clinical trials in multiple sclerosis
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=148140606
FDA is now testing Real-World Evidence and comparing to randomized controlled trials:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=148145719
2018 Conference presentations on pharmacogenomics epidemiology:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=148156807
____________________________________________________________________________________________
GENETICS:
CRISPER discovery of likely MOA for 2-73:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=144274561
DNA and BIOMARKERS (From Mikesc)
https://clinicalepigeneticsjournal.biomedcentral.com/track/pdf/10.1186/s13148-016-0284-4
Apoe4 and Alzheimer's
https://medicalxpress.com/news/2016-08-scientists-reveal-people-apoe4-gene.html
https://www.snpedia.com/index.php/APOE
Anavex 2-73 Won’t Be “Gene Therapy;” Better (from falconer66a)
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=147087396
Health Conditions Related to Genetic Changes
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=147636445
____________________________________________________________________________________________
EPIGENETICS:
Epigenetics and Autoimmune disease:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149317433
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149317468
Anavex sigma-1 receptor agonists may treat epigenetic damage:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=147090448
Mitochondrial dysfunction, disease pathology and epigenetics:
https://learn.genetics.utah.edu/content/epigenetics/inheritance/
Epigenetics and Rett Syndrome:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=147643763
Epigenetic change:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=148594441
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=147910951
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=147927639
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=147906404
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=147900786
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=142496828
Why SSRI's are a FAIL:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=147637039
Fluoride, Epigenetic change and Alzheimer's
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=147640105
Importance of the COMT gene:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=147635325
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=147636055
Childhood abuse, the COMT gene and anger:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=147637039
____________________________________________________________________________________________
SEX DIFFERENCES:
Men, Women, Alzheimer's and gene expression - (from raja45185)
https://www.asianage.com/life/health/060519/new-drugs-to-target-alzheimers.html
Do women have "younger" brains? (from baltimorebullet)
https://www.mprnews.org/story/2019/02/05/npr-scans-show-womens-brains-remain-youthful-as-male-brains-wind-down
Women and Alzheimers:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5934418/
https://www.alz.co.uk/sites/default/files/pdfs/Women-and-Dementia.pdf
Sex hormones and womens' mental health:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=148139054
Genetic Mutations & Estrogen Metabolism (COMT)
https://peacewithendo.com/2015/04/genetic-mutations-estrogen-dominance.html
The elegance of the progesterone theory:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=147783390
The benefits of HRT, if initiated early enough in healthy women, are far greater than the potential adverse effects.
https://www.mja.com.au/journal/2009/190/6/benefits-oestrogen-following-menopause-why-hormone-replacement-therapy-should-be
More on hormone replacement history:
https://www.forbes.com/sites/forbesbooksauthors/2017/04/16/the-long-and-misunderstood-history-of-hormone-replacement-therapy/#47999b23667c
Progesterone:
https://investorshub.advfn.com/boards/read_msgs.aspx?board_id=11474&NextStart=175189&BatchSize=20
Women and Benzodiazepiens:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=145578631
Women and choline:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=146528112
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=146530875
MS and gender bias
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=145789105
Genomic and epigenomic biomarkers are the key to precision medicine.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149763601
____________________________________________________________________________________________
GENETICS INFORMING TRIALS AND PRACTICE:
PHARMACOLOGY + GENOMIC = PHARMACOGENOMICS
The ideal pharmacogenomics test will be able to determine:
• Potential for a medication to be effective – for this person
• The best dose of a medication – for this person
• Avoid risk of serious side effects - for this person
https://www.anavex.com/wp-content/uploads/2019/04/Anavex-Presentation-April-2019.pdf
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149157245
- above is cut and pasted from a georgejjl post
Evolution of clinical trials in multiple sclerosis
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=148140606
FDA is now testing Real-World Evidence and comparing to randomized controlled trials:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=148145719
2018 Conference presentations on pharmacogenomics epidemiology:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=148156807
____________________________________________________________________________________________
GENETICS:
CRISPER discovery of likely MOA for 2-73:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=144274561
DNA and BIOMARKERS (From Mikesc)
https://clinicalepigeneticsjournal.biomedcentral.com/track/pdf/10.1186/s13148-016-0284-4
Apoe4 and Alzheimer's
https://medicalxpress.com/news/2016-08-scientists-reveal-people-apoe4-gene.html
https://www.snpedia.com/index.php/APOE
Anavex 2-73 Won’t Be “Gene Therapy;” Better (from falconer66a)
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=147087396
Health Conditions Related to Genetic Changes
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=147636445
____________________________________________________________________________________________
EPIGENETICS:
Epigenetics and Autoimmune disease:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149317433
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149317468
Anavex sigma-1 receptor agonists may treat epigenetic damage:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=147090448
Mitochondrial dysfunction, disease pathology and epigenetics:
https://learn.genetics.utah.edu/content/epigenetics/inheritance/
Epigenetics and Rett Syndrome:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=147643763
Epigenetic change:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=148594441
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=147910951
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=147927639
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=147906404
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=147900786
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=142496828
Why SSRI's are a FAIL:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=147637039
Fluoride, Epigenetic change and Alzheimer's
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=147640105
Importance of the COMT gene:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=147635325
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=147636055
Childhood abuse, the COMT gene and anger:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=147637039
____________________________________________________________________________________________
SEX DIFFERENCES:
Men, Women, Alzheimer's and gene expression - (from raja45185)
https://www.asianage.com/life/health/060519/new-drugs-to-target-alzheimers.html
Do women have "younger" brains? (from baltimorebullet)
https://www.mprnews.org/story/2019/02/05/npr-scans-show-womens-brains-remain-youthful-as-male-brains-wind-down
Women and Alzheimers:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5934418/
https://www.alz.co.uk/sites/default/files/pdfs/Women-and-Dementia.pdf
Sex hormones and womens' mental health:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=148139054
Genetic Mutations & Estrogen Metabolism (COMT)
https://peacewithendo.com/2015/04/genetic-mutations-estrogen-dominance.html
The elegance of the progesterone theory:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=147783390
The benefits of HRT, if initiated early enough in healthy women, are far greater than the potential adverse effects.
https://www.mja.com.au/journal/2009/190/6/benefits-oestrogen-following-menopause-why-hormone-replacement-therapy-should-be
More on hormone replacement history:
https://www.forbes.com/sites/forbesbooksauthors/2017/04/16/the-long-and-misunderstood-history-of-hormone-replacement-therapy/#47999b23667c
Progesterone:
https://investorshub.advfn.com/boards/read_msgs.aspx?board_id=11474&NextStart=175189&BatchSize=20
Women and Benzodiazepiens:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=145578631
Women and choline:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=146528112
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=146530875
MS and gender bias
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=145789105
Recent AVXL News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/22/2026 12:15:26 PM
- Anavex Life Sciences Receives Expected Nasdaq Delinquency Notification • GlobeNewswire Inc. • 05/22/2026 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2026 08:15:25 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 05/14/2026 08:15:30 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 05/11/2026 08:30:22 PM
- CEO Transition and Delayed SEC Filing Put Anavex (AVXL) Leadership Changes in Focus • IH Market News • 05/06/2026 02:52:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2026 11:04:59 AM
- Anavex Life Sciences Board of Directors Appoints Former Senior Vice President of Clinical Development Terrie Kellmeyer, PhD, as Interim Chief Executive Officer • GlobeNewswire Inc. • 05/06/2026 11:00:00 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 05/01/2026 11:18:47 PM
- Anavex Life Sciences Highlights New Scientific Findings on Shared Biology Between Autism and Alzheimer’s Disease • GlobeNewswire Inc. • 04/14/2026 11:30:00 AM
- Anavex Life Sciences to Present at the 25th Annual Needham Virtual Healthcare Conference • GlobeNewswire Inc. • 04/07/2026 11:30:00 AM
- Anavex withdraws EU approval filing for Alzheimer’s therapy • IH Market News • 03/30/2026 12:39:26 PM
- Anavex Life Sciences Provides Comprehensive Regulatory Update • GlobeNewswire Inc. • 03/30/2026 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/25/2026 08:06:00 PM
- Anavex withdraws EU marketing application for Alzheimer’s therapy blarcamesine • IH Market News • 03/25/2026 02:06:58 PM
- Anavex Life Sciences Provides Update on Regulatory Review in the EU for Blarcamesine to Treat Early Alzheimer’s Disease • GlobeNewswire Inc. • 03/25/2026 11:30:00 AM
- Anavex Life Sciences Presents New Data from its AD-004 Phase IIb/III Trial at AD/PD 2026 Conference Demonstrating Consistent Correlation Between the Treatment Effect of Oral Blarcamesine and Preservation of Brain Volume in Early Alzheimer’s Disease • GlobeNewswire Inc. • 03/23/2026 11:30:00 AM
- New Scientific Findings Highlight Hypothesis of Autophagy Failure as a Precursor of Amyloid Beta and Tau Pathology in Alzheimer’s Disease • GlobeNewswire Inc. • 03/20/2026 11:30:00 AM
- Anavex Life Sciences Presents Significant Treatment Effects of Blarcamesine in New Advanced Alpha-Synuclein Model of Parkinson’s Disease at AD/PD 2026 Conference • GlobeNewswire Inc. • 03/17/2026 11:30:00 AM
- Anavex Life Sciences to Present at the Citizens Life Sciences Conference • GlobeNewswire Inc. • 03/03/2026 12:30:00 PM
- Anavex Life Sciences to Present at the 46th TD Cowen Annual Health Care Conference • GlobeNewswire Inc. • 02/25/2026 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/25/2026 11:07:01 AM
- Anavex Life Sciences Appoints Seasoned Healthcare Leader to Board of Directors • GlobeNewswire Inc. • 02/23/2026 12:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/09/2026 09:40:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/09/2026 12:31:17 PM

